Kuros Biosciences AG (0RHR.L)

CHF 20.55

(1.23%)

Operating Expenses Summary of Kuros Biosciences AG

  • Kuros Biosciences AG's latest annual operating expenses in 2023 was 36.21 Million CHF , up 51.51% from previous year.
  • Kuros Biosciences AG's latest quarterly operating expenses in 2024 Q2 was 28.58 Million CHF , down 0.0% from previous quarter.
  • Kuros Biosciences AG reported a annual operating expenses of 24.21 Million CHF in annual operating expenses 2022, up 28.58% from previous year.
  • Kuros Biosciences AG reported a annual operating expenses of 18.83 Million CHF in annual operating expenses 2021, up 41.07% from previous year.
  • Kuros Biosciences AG reported a quarterly operating expenses of 15.01 Million CHF for 2023 Q2, up 125.61% from previous quarter.
  • Kuros Biosciences AG reported a quarterly operating expenses of 6.65 Million CHF for 2023 Q1, down -50.14% from previous quarter.

Annual Operating Expenses Chart of Kuros Biosciences AG (2023 - 2004)

Historical Annual Operating Expenses of Kuros Biosciences AG (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 36.21 Million CHF 51.51%
2022 24.21 Million CHF 28.58%
2021 18.83 Million CHF 41.07%
2020 13.35 Million CHF 18.01%
2019 11.31 Million CHF 2.6%
2018 11.02 Million CHF -2.21%
2017 11.27 Million CHF -49.68%
2016 22.4 Million CHF 336.1%
2015 5.13 Million CHF -47.76%
2014 9.83 Million CHF -59.47%
2013 24.26 Million CHF 66.26%
2012 14.59 Million CHF -31.43%
2011 21.28 Million CHF -18.8%
2010 26.21 Million CHF -27.88%
2009 36.34 Million CHF -16.66%
2008 43.61 Million CHF 56.83%
2007 27.8 Million CHF 11.05%
2006 25.04 Million CHF -25.64%
2005 33.67 Million CHF 19.04%
2004 28.28 Million CHF 0.0%

Peer Operating Expenses Comparison of Kuros Biosciences AG

Name Operating Expenses Operating Expenses Difference